Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023

25.04.2023 | Original Article

Treatment of Tinnitus with Intratympanic Injection of Dexamethasone Versus Oral Drugs

verfasst von: Arpita Mohanty, Monoj Mukherjee, Siddhartha Kumar Das, Biswajit Sikder

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Tinnitus is a symptom of cochlear dysfunction, which can disturb the patient emotionally and physically. As anxiety and tinnitus persist concurrently, certain benzodiazepines have been administered as possible tinnitus treatment options. In addition to pharmacological medications, certain studies have looked at the use of vitamins to treat tinnitus. Intratympanic steroids have been successfully used in various studies as well, for the treatment of tinnitus. A clinical based interventional study was taken up among the patients visiting the ENT OPD of a State Medical College and Hospital. 160 subjects were included in the study by convenient sampling method, taking the inclusion and the exclusion criteria into consideration. Out of them, 80 subjects were given an intratympanic injection of dexamethasone and rest 80 were given oral drugs like alprazolam and vitamin B complex. Among the patients who were treated with intratympanic dexamethasone, significant improvement was seen in 36 of them, with a p value of 0.00 as compared to those who were given oral drugs, in which only 10 showed improvement, with a p value of 0.32. The improvement of the symptoms is significantly related with the duration of the symptoms in our study. Patients presenting with severe SNHL was the commonest presentation but had the least improvement (29.6%). Patients presenting within one year of occurrence of the symptoms had maximum improvement. Intratympanic dexamethasone can be considered as a good alternative for improvement of symptoms of tinnitus.
Literatur
1.
Zurück zum Zitat Beebe Palumbo D, Joos K, De Ridder D, Vanneste S (2015) The management and outcomes of pharmacological treatments for tinnitus. Curr Neuropharmacol 13:692–700CrossRefPubMed Beebe Palumbo D, Joos K, De Ridder D, Vanneste S (2015) The management and outcomes of pharmacological treatments for tinnitus. Curr Neuropharmacol 13:692–700CrossRefPubMed
2.
Zurück zum Zitat Johnson RM, Brummett R, Schleuning A (1993) Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 119:842–845CrossRefPubMed Johnson RM, Brummett R, Schleuning A (1993) Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 119:842–845CrossRefPubMed
3.
Zurück zum Zitat Jastreboff PJ, Hazell JWP (1993) A neurophysiological approach to tinnitus; clinical implications. Br J Audiol 27:7–17CrossRefPubMed Jastreboff PJ, Hazell JWP (1993) A neurophysiological approach to tinnitus; clinical implications. Br J Audiol 27:7–17CrossRefPubMed
4.
Zurück zum Zitat Hazell JWP (1966) Support for a neurophysiological model of tinnitus. In: Vernon GE, Vernon JA (eds). Proceedings of the fifth international tinnitus seminar. Portland, Oregon: American tinnitus Association, pp 51–7 Hazell JWP (1966) Support for a neurophysiological model of tinnitus. In: Vernon GE, Vernon JA (eds). Proceedings of the fifth international tinnitus seminar. Portland, Oregon: American tinnitus Association, pp 51–7
5.
Zurück zum Zitat Sakata E, Kitago Y, Murata Y, Teramoto K (1986) Treatment of Meniere’s disease. Middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx 13:79–89CrossRefPubMed Sakata E, Kitago Y, Murata Y, Teramoto K (1986) Treatment of Meniere’s disease. Middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx 13:79–89CrossRefPubMed
6.
Zurück zum Zitat Chandrasekhar SS (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22:18–23CrossRefPubMed Chandrasekhar SS (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22:18–23CrossRefPubMed
7.
Zurück zum Zitat Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17CrossRefPubMed Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17CrossRefPubMed
8.
Zurück zum Zitat Pitovski DZ, Drescher MJ, Drescher DG (1994) Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 77:216–20CrossRefPubMed Pitovski DZ, Drescher MJ, Drescher DG (1994) Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 77:216–20CrossRefPubMed
9.
Zurück zum Zitat Rarey KE, Lohuis PJ, ten Cate WJ (1991) Response of the stria vascularis to corticosteroids. Laryngoscope 101:1081–4CrossRefPubMed Rarey KE, Lohuis PJ, ten Cate WJ (1991) Response of the stria vascularis to corticosteroids. Laryngoscope 101:1081–4CrossRefPubMed
10.
Zurück zum Zitat Trune DR, Kempton JB, Gross ND (2006) Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 212:22–32CrossRefPubMed Trune DR, Kempton JB, Gross ND (2006) Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 212:22–32CrossRefPubMed
11.
Zurück zum Zitat Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ et al (2011) Oral versus intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss. JAMA 305:2071–2079CrossRefPubMed Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ et al (2011) Oral versus intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss. JAMA 305:2071–2079CrossRefPubMed
12.
Zurück zum Zitat Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl). Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl).
13.
Zurück zum Zitat Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A (2011) Intratympanic steroid therapy for sudden hearing loss: a review of the literature. OtolNeurotol 32:29–35 Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A (2011) Intratympanic steroid therapy for sudden hearing loss: a review of the literature. OtolNeurotol 32:29–35
14.
Zurück zum Zitat Sakata E, Itoh A, Itoh Y (1996) Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 2:129–135PubMed Sakata E, Itoh A, Itoh Y (1996) Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 2:129–135PubMed
15.
Zurück zum Zitat Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D (2002) Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience. Int Tinnitus J 8:111–114PubMed Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D (2002) Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience. Int Tinnitus J 8:111–114PubMed
16.
Zurück zum Zitat Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H et al (2007) Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 117:415–420CrossRefPubMed Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H et al (2007) Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 117:415–420CrossRefPubMed
17.
Zurück zum Zitat Shim HJ, Kim SK, Park CH, Lee SH, Yoon SW, Ki AR et al (2009) Hearing abilities at ultrahigh frequency in patients with tinnitus. Clin Exp Otorhinolaryngo 2:169–174CrossRef Shim HJ, Kim SK, Park CH, Lee SH, Yoon SW, Ki AR et al (2009) Hearing abilities at ultrahigh frequency in patients with tinnitus. Clin Exp Otorhinolaryngo 2:169–174CrossRef
18.
Zurück zum Zitat Job A, Raynal M, Kossowski M (2007) Susceptibility to tinnitus revealed at 2 kHz range by bilateral lower DPOAEs in normal hearing subjects with noise exposure. AudiolNeurootol 12:137–44 Job A, Raynal M, Kossowski M (2007) Susceptibility to tinnitus revealed at 2 kHz range by bilateral lower DPOAEs in normal hearing subjects with noise exposure. AudiolNeurootol 12:137–44
19.
Zurück zum Zitat Ami M, Abdullah A, Awang MA, Liyab B, Saim L (2008) Relation of distortion product otoacoustic emission with tinnitus. Laryngoscope 118:712–717CrossRefPubMed Ami M, Abdullah A, Awang MA, Liyab B, Saim L (2008) Relation of distortion product otoacoustic emission with tinnitus. Laryngoscope 118:712–717CrossRefPubMed
20.
Zurück zum Zitat Hamid M, Trune D (2008) Issues, indications, and controversies regarding intratympanic steroid perfusion. CurrOpinOtolaryngol Head Neck Surg 16:434–440 Hamid M, Trune D (2008) Issues, indications, and controversies regarding intratympanic steroid perfusion. CurrOpinOtolaryngol Head Neck Surg 16:434–440
21.
Zurück zum Zitat Shulman A, Goldstein B (2000) Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 6:10–20PubMed Shulman A, Goldstein B (2000) Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 6:10–20PubMed
22.
Zurück zum Zitat Araujo MF, Oliveira CA, Bahmad FM Jr (2005) Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 131:113–117CrossRefPubMed Araujo MF, Oliveira CA, Bahmad FM Jr (2005) Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 131:113–117CrossRefPubMed
23.
Zurück zum Zitat Yoshida T, Teranishi M, Iwata T, Otake H, Nakashima T (2012) Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss. Audiol Res 2:e2CrossRefPubMedPubMedCentral Yoshida T, Teranishi M, Iwata T, Otake H, Nakashima T (2012) Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss. Audiol Res 2:e2CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Berkiten G, Yildirim G, Topaloglu I, Ugras H (2013) Vitamin B12 levels in patients with tinnitus and effectiveness of vitamin B12 treatment on hearing threshold and tinnitus. BENT 9:111–116 Berkiten G, Yildirim G, Topaloglu I, Ugras H (2013) Vitamin B12 levels in patients with tinnitus and effectiveness of vitamin B12 treatment on hearing threshold and tinnitus. BENT 9:111–116
Metadaten
Titel
Treatment of Tinnitus with Intratympanic Injection of Dexamethasone Versus Oral Drugs
verfasst von
Arpita Mohanty
Monoj Mukherjee
Siddhartha Kumar Das
Biswajit Sikder
Publikationsdatum
25.04.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-03795-1

Weitere Artikel der Ausgabe 3/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.